DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/xlv2ff/global_lung) has announced the addition of the "Global Lung Cancer Pipeline Capsule - 2013" report to their offering.
Fore Pharma's latest report Global Lung Cancer Pipeline Capsule - 2013' provides up-to-date information on key Research and Development (R&D) activities in the global lung cancer market. It covers active lung cancer pipeline molecules in clinical trials, preclinical research, and drug discovery.
This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The scope of the report includes information on lung cancer pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Lung cancer pipeline molecules licensing activities are also covered in this report.
Key Features of the Report:
- Lung cancer Pipeline Overview
- Lung cancer Phase 3 Clinical Trial Pipeline
- Lung cancer Phase 2 Clinical Trial Pipeline
- Lung cancer Phase 1 Clinical Trial Pipeline
- Lung cancer Preclinical Research Pipeline
- Lung cancer Drug Discovery Stage Pipeline
- Lung cancer Pipeline in the U.S.
- Lung cancer Pipeline in Europe
- Licensing Activities in Global Lung Cancer Market
For more information visit http://www.researchandmarkets.com/research/xlv2ff/global_lung
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Lung Cancer
